Notch signaling is not essential in sonic hedgehog-activated medulloblastoma.
Ontology highlight
ABSTRACT: Dysregulated signal transduction through the notch pathway has been noted in human and mouse medulloblastoma studies. Gamma secretase inhibitors (GSIs) impair notch signaling by preventing the cleavage of transmembrane notch proteins into their active intracellular domain fragments. Previous studies have shown that GSI treatment caused apoptosis and impaired medulloblastoma cell engraftment in xenograft systems. In this study, we used in vivo genetic and pharmacologic approaches to quantify the contribution of notch signaling to sonic hedgehog (shh)-activated mouse medulloblastoma models. In contrast to prior in vitro studies, pharmacologic inhibition of notch pathways did not reduce the efficiency of medulloblastoma xenotransplantation nor did systemic therapy impact tumor size, prolifera
SUBMITTER: Hatton BA
PROVIDER: S-EPMC2896441 | biostudies-literature | 2010 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA